Standard
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol : A Prospective Analysis of the IMPACT Trial. / Han, M. K.; Criner, G. J.; Dransfield, M. T.; Halpin, D. M. G.; Jones, C. E.; Kilbride, S.; Lange, P.; Lipson, D. A.; Lomas, D. A.; Martinez, F. J.; Naya, I.; Pascoe, S. J.; Wise, R. A.; Singh, D.
I:
American Journal of Respiratory and Critical Care Medicine, Bind 199, Nr. A2438, A102, 2019.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Han, MK, Criner, GJ, Dransfield, MT, Halpin, DMG, Jones, CE, Kilbride, S
, Lange, P, Lipson, DA, Lomas, DA, Martinez, FJ, Naya, I, Pascoe, SJ, Wise, RA & Singh, D 2019, '
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial',
American Journal of Respiratory and Critical Care Medicine, bind 199, nr. A2438, A102.
https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438APA
Han, M. K., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Jones, C. E., Kilbride, S.
, Lange, P., Lipson, D. A., Lomas, D. A., Martinez, F. J., Naya, I., Pascoe, S. J., Wise, R. A., & Singh, D. (2019).
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial.
American Journal of Respiratory and Critical Care Medicine,
199(A2438), [A102].
https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438Vancouver
Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S o.a.
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial.
American Journal of Respiratory and Critical Care Medicine. 2019;199(A2438). A102.
https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438Author
Han, M. K. ; Criner, G. J. ; Dransfield, M. T. ; Halpin, D. M. G. ; Jones, C. E. ; Kilbride, S. ; Lange, P. ; Lipson, D. A. ; Lomas, D. A. ; Martinez, F. J. ; Naya, I. ; Pascoe, S. J. ; Wise, R. A. ; Singh, D. / Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol : A Prospective Analysis of the IMPACT Trial. I: American Journal of Respiratory and Critical Care Medicine. 2019 ; Bind 199, Nr. A2438.
Bibtex
@article{47ffc183ffb24775a93a359268703cf4,
title = "Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial",
author = "Han, {M. K.} and Criner, {G. J.} and Dransfield, {M. T.} and Halpin, {D. M. G.} and Jones, {C. E.} and S. Kilbride and P. Lange and Lipson, {D. A.} and Lomas, {D. A.} and Martinez, {F. J.} and I. Naya and Pascoe, {S. J.} and Wise, {R. A.} and D. Singh",
year = "2019",
doi = "10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438",
language = "English",
volume = "199",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "A2438",
}
RIS
TY - ABST
T1 - Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol
T2 - A Prospective Analysis of the IMPACT Trial
AU - Han, M. K.
AU - Criner, G. J.
AU - Dransfield, M. T.
AU - Halpin, D. M. G.
AU - Jones, C. E.
AU - Kilbride, S.
AU - Lange, P.
AU - Lipson, D. A.
AU - Lomas, D. A.
AU - Martinez, F. J.
AU - Naya, I.
AU - Pascoe, S. J.
AU - Wise, R. A.
AU - Singh, D.
PY - 2019
Y1 - 2019
U2 - 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438
DO - 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438
M3 - Conference abstract in journal
VL - 199
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
SN - 1073-449X
IS - A2438
M1 - A102
ER -
